COST Action CA18218

[Webinar] Initial insights from the Global Burden of Disease 2020 study

Date to be confirmed

About the webinar

The Global Burden of Disease (GBD) study is the most comprehensive international epidemiologcal study to date, led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Seattle, USA. The study is a key resource in understanding the changing population health issues, facing countries across the world. In the 2019 study, population health trends were examined from 1990 to 2019, including insights on mortality and morbidity in 204 countries and territories, 369 diseases and injuries, and 87 risk factors. By tracking progress within and between countries, it provides an important tool to inform clinicians, researchers, and policy makers, promote accountability, and improve lives worldwide. The forthcoming GBD 2020 will be the first study iteration to incorporate the population health impact of COVID-19.

In this webinar, initial insights on findings from the Global Burden of Disease 2020 study will be presented.


  Welcome & Introduction
— Prof Dr Brecht Devleesschauwer, Action Chair, Sciensano, Belgium
  Initial insights from the Global Burden of Disease 2020 study
— Prof Dr Theo Vos, Institute for Health Metrics and Evaluation, USA
  Questions and answers


Theo Vos
Theo Vos

Professor Dr Theo Vos, MD, MSc, PhD, is a Professor of Health Metrics Sciences at the IHME at the University of Washington. He is a key member of the research team for the landmark GBD study, which is coordinated by IHME. In this role, he is working to improve the GBD methods, update sources of data, and develop partnerships with countries and disease experts to produce GBD estimates that are most relevant to policy decision-making. He is also focused on linking the epidemiological estimates from GBD to information on health expenditure and cost-effectiveness.

Professor Dr. Vos received his PhD in Epidemiology and Health Economics from Erasmus University and his medical degree from State University Groningen, both in the Netherlands. He also studied at the London School of Hygiene and Tropical Medicine, where he obtained an MSc in Public Health in Developing Countries.

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini